STUDIES OF PHOTOTHERAPY AND FREE RADICAL LYMPHOKINE RELATIONSHIPS
STUDIES OF PHOTOTHERAPY AND FREE RADICAL LYMPHOKINE RELATIONSHIPS
批准号:
3838091
负责人:
H I PASS
金额:
$0.0万
依托单位国家:
美国
项目类别:
财政年份:
--
资助国家:
美国
项目状态:
未结题
起止时间:
至
关键词:
biological models clinical trials human subject human therapy evaluation immunoconjugates lipopolysaccharides macrophage macrophage activating factor medical complication monoclonal antibody neoplasm /cancer photoradiation therapy photosensitizing agents pleural neoplasms radiation therapy dosage tumor necrosis factor alpha
中文摘要
我们的实验室正在继续研究光动力疗法
对恶性肿瘤的治疗。我们已经证明了
针对弱致敏剂的单抗将提高特异性,因为
以及在体内光动力疗法模型中的长期治愈。
我们继续在人体试验中进行调查,以确定最大
胸腔内分娩的耐受量的光疗。截至6月
1992年,42名患者接受了胸腔内光动力检查
在三名患者的队列中进行小剂量递增治疗试验。
我们已经发布了通过这些设备监控光线的能力
治疗。我们已经证明,最大耐受量
术中胸膜光动力疗法是30焦耳/厘米平方
在24小时剂量为2毫克/公斤的Photofrin II后,我们发现
次高剂量的光疗光(32.5焦耳/厘米平方)
导致食道并发症。我们还调查了使用
一些新的化合物可以预防肿瘤坏死因子的毒性。
钾通道激活剂尼可地尔被发现减少
内毒素刺激产生巨噬细胞肿瘤坏死因子可能通过
呼吸爆发的减少。此外,还发现硝化PBN
下调血清水平消除内毒素在体内的致死性
肿瘤坏死因子的产生。其他化合物的研究
在预防细胞因子毒性方面可能有用的是
继续我们这一节的体外和活体模型。
英文摘要
Our laboratory has continued investigation of photodynamic therapy for
the treatment of malignancy. We have shown that conjugation of
monoclonal antibody to a weak sensitizer will improve the specificity as
well as the long-term cures in an in vivo model of photodynamic therapy.
We continue with investigations in human trials to establish the maximum
tolerated dose of phototherapy for intrapleural delivery. As of June of
1992 42 patients have been entered on an intrapleural photodynamic
therapy trial with light dose escalation in cohorts of three patients.
We have published the ability to monitor the light through these
treatments. We have shown that the maximum tolerated dose of
intraoperative pleural photodynamic therapy is 30 Joules/cm-squared of
light after a 24 hour dosing of 2 mg/kg of Photofrin II. We found the
next highest dose of phototherapy light (32.5 Joules/cm-squared)
resulted in esophageal complications. We have also investigated use of
a number of novel compounds to prevent tumor necrosis factor toxicity.
Potassium channel activator, Nicorandil, was found to decrease
macrophage TNF production from an LPS challenge possibly through a
reduction in respiratory burst. Moreover, the nitron PBN was found to
abrogate the lethality of LPS in vivo through down regulation of serum
production of tumor necrosis factor. Investigations of other compounds
which may be useful in protecting against cytokine toxicity is
continuing in our section within in vitro and in vivo models.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
STUDIES ON THE TREATMENT AND CHARACTERISTICS OF THORACIC MALIGNANCIES
-
批准号:3774606
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:H I PASS
-
依托单位:
STUDIES OF PHOTOTHERAPY FOR THORACIC MALIGNANCIES
-
批准号:3916630
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:H I PASS
-
依托单位:
STUDIES OF PHOTOTHERAPY FOR THORACIC MALIGNANCIES
-
批准号:3874452
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:H I PASS
-
依托单位:
STUDIES OF PHOTOTHERAPY FOR THORACIC MALIGNANCIES
-
批准号:3939564
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:H I PASS
-
依托单位:
STUDIES ON THE TREATMENT AND CHARACTERISTICS OF THORACIC MALIGNANCIES
-
批准号:3752366
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:H I PASS
-
依托单位:
STUDIES ON THE TREATMENT AND CHARACTERISTICS OF THORACIC MALIGNANCIES
-
批准号:2464450
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:H I PASS
-
依托单位:
STUDIES OF PHOTOTHERAPY AND FREE RADICAL LYMPHOKINE RELATIONSHIPS
-
批准号:3853218
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:H I PASS
-
依托单位:
STUDIES ON THE TREATMENT AND CHARACTERISTICS OF THORACIC MALIGNANCIES
-
批准号:5201289
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:H I PASS
-
依托单位:
海外基金